Defence Profits Reach Dharavi's Machinists
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
Fundamentals for CRISIL Limited
Business Operations:
Sector: Financial ServicesIndustry: Financial Data & Stock Exchanges
CRISIL Limited, an analytical company, together with its subsidiaries, provides ratings, data, research, and analytics and solutions worldwide. It operates through two segment, Rating Services; and Research, Analytics, and Solutions. The Ratings Services segment offers credit ratings for corporates, banks, and bank loans; credit analysis services; grading services; and analytical services. The Research, Analytics, and Solutions segment provides research and risk solutions, industry reports, customized research assignments, subscription to data services, independent equity research, initial public offering gradings, training, credit ratings for small and medium enterprises, and advisory services; and range of risk management tools, analytics, and solutions for financial institutions, banks, and corporates. The company was formerly known as The Credit Rating Information Services of India Limited and changed its name to CRISIL Limited in December 2003. CRISIL Limited was incorporated in 1987 and is headquartered in Mumbai, India.
Revenue projections:
CRISIL's projected revenue decline from last year is likely to make investors cautious. Lower revenues often hurt a company's bottom line, leading investors to be concerned about the company's ability to maintain profitability and deliver strong financial results in the future.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 28.330114 |
| debtToEquity | 9.785000 |
| earningsGrowth | 0.459000 |
| revenueGrowth | 0.301000 |
| grossMargins | 0.467730 |
| operatingMargins | 0.263930 |
| trailingEps | 114.940000 |
| forwardEps | 150.723000 |
CRISIL's Forward PE being in a good range suggests that its stock price is aligned well with earnings. The stock is not considered overpriced, offering room for future growth, which makes it an appealing investment opportunity with the potential for value appreciation.
With positive earnings and revenue growth, CRISIL is on a path to expand its business. This strong financial performance suggests the company will continue to grow, as increasing profits and revenue highlight a healthy outlook.
CRISIL Limited's positive gross and operating margins suggest strong profitability. These margins reflect effective cost management and revenue generation, indicating that the company is efficiently managing its operations and maintaining financial health.
CRISIL's forward EPS is higher than its trailing EPS, which signals that the company is expected to achieve greater profitability this financial year. This suggests improved earnings performance, indicating a positive outlook for CRISIL's financial growth.
Price projections:
CRISIL Limited's present price, in comparison to its projections, indicates no evident risks or opportunities. This balanced scenario suggests a steady environment, where investors might choose to wait for more definitive indicators before altering their strategies.
Recommendation changes over time:
The recent sell bias from analysts on CRISIL Limited suggests investors should be cautious. However, it's a good idea to base decisions on a broader range of market indicators to gain a more complete and accurate view of the stock's potential performance in the near term.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy